influenza
viru
iav
infect
pose
seriou
health
threat
novel
antivir
strategi
need
defect
interf
particl
dip
gener
iav
infect
cell
due
error
viral
polymeras
may
suppress
spread
wild
type
wt
viru
antivir
activ
dip
exert
di
genom
rna
segment
usual
contain
larg
delet
suppress
amplif
wt
segment
potenti
compet
cellular
viral
resourc
natur
occur
prototyp
segment
di
rna
open
read
frame
delet
current
develop
antivir
therapi
present
coinfect
wt
viru
requir
product
particl
rais
concern
regard
biosafeti
may
complic
interpret
research
result
show
cocultur
mdck
cell
line
stabli
express
codon
optim
allow
product
particl
sole
plasmid
absenc
helper
viru
moreov
demonstr
infect
particl
quantifi
use
cell
final
report
particl
produc
novel
system
exert
potent
antivir
activ
iav
unrel
vesicular
stomat
viru
first
report
dip
product
absenc
infecti
iav
may
spur
effort
develop
dip
antivir
therapi
influenza
viru
infect
respons
annual
influenza
epidem
intermitt
pandem
associ
signific
morbid
mortal
abil
iav
constantli
chang
respons
immun
pressur
antivir
treatment
limit
effect
current
use
antivir
intervent
thu
vaccin
season
influenza
need
annual
reformul
provid
littl
protect
pandem
influenza
moreov
effect
antivir
target
viral
protein
neuraminidas
compromis
frequent
emerg
transmiss
resist
mutat
therefor
novel
approach
combat
influenza
urgent
need
iav
envelop
harbor
eight
segment
genom
viral
rna
defect
interf
di
genom
segment
gener
iav
infect
cell
due
error
viral
polymeras
di
segment
usual
harbor
larg
delet
inactiv
open
read
frame
encod
segment
di
segment
interfer
amplif
wild
type
wt
segment
potenti
compet
viral
cellular
resourc
requir
segment
replic
moreov
di
rna
packag
progeni
virion
term
defect
interf
particl
dip
coinfect
target
cell
dip
iav
result
preferenti
amplif
dip
suppress
iav
spread
effect
observ
cell
cultur
experiment
infect
anim
may
extend
unrel
virus
due
activ
interferon
system
moreov
dip
applic
therapeut
prevent
set
prevent
amelior
influenza
anim
model
sum
dip
consid
natur
antivir
produc
context
infect
iav
mani
virus
may
provid
basi
develop
new
strategi
antivir
intervent
present
amplif
dip
requir
coinfect
cell
dip
wt
viru
term
standard
helper
viru
subsequ
need
inactiv
uv
light
presenc
standard
viru
pose
safeti
concern
product
anim
human
use
gener
complic
interpret
experiment
data
plasmid
system
encod
wt
di
segment
along
cell
line
express
iav
protein
genom
inform
lost
upon
di
rna
format
might
circumv
issu
howev
express
viral
polymeras
subunit
tran
found
insuffici
robust
amplif
iav
variant
harbor
temperatur
sensit
mutat
specul
similar
limit
might
appli
product
dip
moreov
suggest
express
might
toxic
cell
therefor
current
unknown
whether
strategi
outlin
might
allow
product
segment
dip
present
system
gener
dip
absenc
standard
viru
report
natur
occur
dirna
found
hen
egg
deriv
segment
encod
harbor
nucleotid
compris
delet
delet
remov
orf
leav
nucleotid
nucleotid
segment
intact
suffici
segment
replic
packag
investig
whether
coexpress
wt
segment
protein
rna
allow
product
dip
employ
novel
variant
encod
mscarleti
show
dip
effici
produc
cell
express
codon
optim
version
dip
exert
potent
antivir
activ
plasmid
rescu
strain
use
throughout
studi
previous
describ
gener
retrovir
vector
encod
open
read
frame
amplifi
use
primer
clone
retrovir
vector
pqcxipmc
use
noti
xhoi
selfinactiv
vector
allow
constitut
express
puromycin
resist
gene
coupl
intern
ribosom
entri
site
ire
optim
sequenc
gener
hand
maxim
sequenc
deviat
optim
codon
usag
influenza
viru
human
fig
sequenc
synthes
clone
geneart
regensburg
germani
subclon
use
noti
xhoi
site
pqcxipmc
plasmid
rescu
gener
splice
overlap
pcr
use
templat
primer
pair
flua
flua
tctctat
product
splice
overlap
pcr
purifi
amplifi
segment
specif
primer
pair
flua
clone
use
golden
gate
clone
gener
addit
construct
contain
multipl
clone
site
mc
gener
later
insert
report
gene
pcr
fragment
amplifi
use
templat
primer
pair
flua
cagttaagcggccgctgcggtaccagatctcttctcctgtcttcc
gcggccgcttaactg
flua
follow
splice
overlap
join
golden
gate
clone
report
gene
mscarleti
without
intern
sali
noti
site
fuse
porcin
sequenc
gatnfsllkqagdveenpgp
clone
mc
bgliinoti
fragment
way
aa
orf
gener
allow
detect
presenc
via
mscarleti
fluoresc
templat
mscarleti
gift
doru
gadella
addgen
plasmid
integr
pcramplifi
clone
sequenc
verifi
sequenc
analysi
cell
cultur
co
human
embryon
kidney
cell
vero
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
contain
fetal
bovin
serum
fb
gibco
penicillin
pen
iuml
streptomycin
strep
ml
cell
line
stabli
express
grown
presenc
puromycin
madindarbi
canin
kidney
cell
mdck
cultur
glasgow
mem
gmem
fetal
bovin
serum
fb
gibco
penstrep
cell
line
obtain
collabor
regularli
check
mycoplasma
contamin
mdck
cell
stabli
express
cultiv
presenc
puromycin
influenza
virus
produc
embryon
chicken
egg
use
assess
antivir
activ
dip
employ
recombin
vesicular
stomat
viru
vsv
express
dual
report
consist
egfp
firefli
luciferas
addit
transcript
unit
locat
open
read
frame
viral
glycoprotein
polymeras
product
mlv
particl
transduct
cell
follow
establish
protocol
briefli
cell
seed
flask
transfect
retrovir
vector
eg
mlvgagpol
plasmid
vsvg
express
plasmid
employ
calcium
phosphat
transfect
method
cultur
medium
exchang
h
transfect
h
mlv
particlecontain
supernat
harvest
clear
pass
filter
aliquot
store
retrovir
transduct
cell
seed
plate
mdck
cellswel
cell
cultur
medium
next
day
supernat
contain
mlv
particl
ad
per
well
follow
spinocul
g
min
enhanc
transduct
two
day
transduct
cell
detach
transfer
plate
contain
cell
cultur
medium
supplement
mdck
puromycin
parallel
nontransduc
cell
treat
similarli
control
effect
cell
kill
antibiot
seed
cell
densiti
cellswel
plate
follow
day
cell
transfect
use
calcium
phosphat
method
concentr
plasmid
transfect
larg
adapt
publish
work
ng
pcagg
plasmid
encod
viral
rna
polymeras
protein
pb
pa
ng
plasmid
encod
np
cotransfect
ng
plasmid
ppoliluc
encod
firefli
luciferas
report
gene
flank
noncod
region
segment
empti
plasmid
use
ensur
transfect
conduct
total
amount
plasmid
dna
analysi
function
cell
stabli
express
protein
transfect
carri
describ
plasmid
encod
omit
control
plasmid
encod
omit
cell
wash
h
transfect
harvest
h
post
transfect
luciferas
activ
cell
lysat
measur
use
plate
chameleon
v
plate
reader
hidex
microwin
softwar
analysi
express
mdck
cell
cell
seed
plate
incub
h
harvest
lyse
laemmli
sdspage
sampl
buffer
glycerin
sd
bromophenol
blue
mm
tri
ph
sampl
heat
min
separ
via
sdspage
use
polyacrylamid
gel
protein
transfer
onto
nitrocellulos
membran
ge
health
care
use
miniprotean
tetra
cell
biorad
power
v
minut
membran
block
skim
milk
dilut
pbstween
incub
primari
rabbit
polyclon
antibodi
gentex
irvin
usa
overnight
subsequ
membran
wash
incub
antirabbit
hrp
horseradish
peroxidas
conjug
secondari
antibodi
dianova
one
hour
final
chemiluminesc
substrat
hrp
juic
plu
pjk
ad
onto
membran
band
visual
use
chemocam
imag
inta
order
detect
membran
subsequ
strip
use
strip
buffer
mm
tri
hcl
ph
sd
mm
min
wash
three
time
pbstween
incub
anti
mous
sigmaaldrich
overnight
membran
wash
incub
antimous
hrpconjug
secondari
antibodi
dianova
one
hour
hrp
juic
plu
ad
band
visual
previous
describ
quantif
express
carri
use
program
imagej
fiji
distribut
order
normal
data
signal
measur
divid
measur
betaactin
dip
product
cocultur
mdck
cell
cell
stabli
express
seed
flask
next
day
cell
cotransfect
via
calcium
phosphat
method
plasmid
encod
wt
iav
genom
segment
cultur
medium
chang
h
post
transfect
h
post
transfect
cell
wash
phosphat
buffer
salin
pb
without
calcium
magnesium
dmem
medium
supplement
bsa
mac
bsa
tosylphenylalanychloromethylketon
tpck
trypsin
sigma
penicillin
iuml
streptomycin
ml
ad
neg
control
transfect
parent
mdck
cell
analyz
supernat
harvest
cultur
day
post
transfect
clear
centrifug
rpm
min
remov
debri
aliquot
store
infect
supernat
analyz
focu
format
assay
describ
use
mdck
cell
express
target
brief
cell
seed
plate
wash
incub
h
serial
dilut
dipcontain
supernat
thereaft
supernat
remov
infect
medium
gmem
bsa
pen
strep
supplement
methylcellulos
tpcktrypsin
ad
plate
incub
h
stain
use
anti
iav
polyclon
antibodi
millipor
imag
taken
zeiss
equip
planapochromat
object
nm
nm
diod
laser
zen
imag
softwar
zeiss
fluoresc
signal
red
channel
nm
laser
detect
gaasp
detector
employ
sensit
imag
seri
bright
field
signal
record
esid
detector
photodiod
individu
adjust
sensit
test
antivir
activ
dip
iav
unrel
vsv
perform
infect
experi
presenc
dipcontain
dipfre
supernat
subsequ
compar
viral
titer
cultur
supernat
mdck
cell
seed
plate
densiti
cellswel
next
day
dipcontain
supernat
dipfre
control
supernat
serial
dilut
subsequ
mdck
cell
wash
twice
pb
respect
supernat
mix
viru
mixtur
inocul
onto
mdck
cell
h
incub
fresh
infect
medium
supplement
tpcktrypsin
ad
cell
incub
h
vsv
h
iav
viral
titer
cultur
supernat
determin
viru
titrat
perform
confluent
monolay
mdck
iav
vero
vsv
cell
grown
plate
aspir
cultur
medium
cell
wash
twice
pb
inocul
serial
dilut
cultur
supernat
iav
vsv
infect
mdck
cell
h
incub
iav
contain
supernat
medium
remov
infect
medium
supplement
avicel
tpcktrypsin
iavmdck
ad
per
well
incub
vsvcontain
supernat
infect
medium
supplement
methylcellulos
vsvvero
ad
top
cell
incub
h
iav
titer
quantifi
antibodi
stain
use
focu
format
assay
previous
describ
order
quantifi
vsv
titer
egfpposit
foci
count
fluoresc
microscop
titer
given
focu
form
unit
per
ml
ffuml
sought
determin
whether
particl
amplifi
absenc
standard
viru
produc
cell
engin
express
first
use
retrovir
transduct
select
antibiot
gener
mdck
cell
line
stabli
express
immunoblot
reveal
cell
line
obtain
select
express
robust
level
fig
fig
order
analyz
whether
function
cell
employ
minireplicon
system
measur
amplif
firefli
luciferas
encod
iav
report
segment
upon
coexpress
pa
np
found
transfect
cell
plasmid
encod
report
segment
alon
yield
luciferas
activ
background
rang
cotransfect
pa
np
express
plasmid
increas
luciferas
activ
fig
importantli
increas
observ
plasmid
omit
omiss
plasmid
impact
report
activ
fig
thu
protein
stabli
express
cell
function
unfortun
similar
studi
mdck
cell
feasibl
due
low
transfect
cell
next
investig
whether
cell
allow
gener
particl
use
experiment
setup
depict
fig
order
abl
visual
inspect
product
spread
gener
variant
encod
mscarleti
red
fluoresc
protein
transfect
mixtur
cell
plasmid
encod
iav
wt
segment
jointli
plasmid
encod
result
occasion
moder
red
fluoresc
fig
contrast
frequent
promin
red
fluoresc
observ
cocultur
fig
indic
stabli
express
promot
amplif
di
rna
order
examin
whether
amplif
di
rna
result
product
infecti
dip
supernat
transfect
cell
inocul
onto
cell
fig
control
supernat
also
ad
mdck
wt
cell
inocul
cell
supernat
cell
result
infect
target
cell
determin
express
mscarleti
fig
number
mscarletiposit
cell
concentr
depend
supernat
taken
day
post
transfect
dip
produc
cell
contain
highest
amount
infect
fig
final
cell
promin
red
fluoresc
detect
control
condit
indic
dip
infecti
mdck
wt
cell
next
ask
whether
product
could
quantifi
focu
format
assay
base
detect
iav
antigen
antibodi
stain
frequent
employ
measur
iav
infect
moreov
examin
whether
result
obtain
focu
format
assay
would
match
obtain
upon
count
foci
base
upon
red
fluoresc
foci
observ
mdck
control
cell
confirm
dip
infect
requir
express
target
cell
quantif
dip
infect
focu
format
assay
reveal
maximum
titer
roughli
x
dip
per
ml
obtain
count
red
fluoresc
foci
yield
roughli
compar
result
fig
fig
thu
express
suffici
product
absenc
helper
viru
product
effici
moder
dip
titer
x
particl
per
ml
low
may
limit
experiment
therefor
next
ask
whether
alter
codon
usag
express
might
increas
express
effici
dip
product
modifi
codon
express
plasmid
fig
reflect
codon
prefer
human
gene
iav
second
criterion
codon
choic
opt
maxim
sequenc
differ
sequenc
previous
use
express
newli
gener
optim
sequenc
order
prevent
potenti
recombin
event
mdck
cell
engin
stabli
express
immunoblot
reveal
express
level
mdck
cell
higher
obtain
upon
express
noncodonoptim
fig
fig
moreov
growth
cell
compar
control
cell
express
readili
detect
multipl
passag
suggest
express
associ
overt
cytotox
final
analysi
averag
five
experi
conduct
describ
panel
quantifi
via
imagej
program
shown
signal
measur
normal
measur
betaactin
error
bar
indic
standard
error
mean
sem
two
tail
pair
student
ttest
use
assess
statist
signific
c
cell
stabli
express
cotransfect
plasmid
encod
iav
luciferas
report
segment
indic
iav
protein
luciferas
activ
cell
lysat
determin
h
post
transfect
result
repres
experi
carri
triplic
sampl
shown
error
bar
indic
standard
deviat
two
tail
pair
student
ttest
use
assess
statist
signific
similar
result
obtain
three
separ
experi
cp
count
per
second
http
new
system
product
defect
interf
particl
cell
minireplicon
assay
show
support
iav
segment
replic
fig
next
examin
whether
support
dip
product
higher
effici
unmodifi
effici
di
rna
amplif
observ
transfect
cell
shown
supernat
obtain
cell
highli
infecti
cell
even
dilut
fig
contrast
supernat
infecti
mdck
cell
fig
moreov
direct
comparison
cell
product
infecti
dip
dip
amplif
upon
infect
reveal
cell
effici
thu
red
fluoresc
cell
observ
supernat
express
cell
ad
compar
cell
fig
similarli
supernat
cell
infecti
target
cell
compar
cell
keep
observ
quantif
product
infecti
dip
focu
format
assay
count
red
fluoresc
cell
reveal
least
foci
identifi
antibodi
stain
posit
mscarleti
expect
cell
produc
x
infecti
dip
per
ml
therebi
exceed
titer
obtain
cell
x
fig
fig
inhibit
spread
divers
iav
like
via
induct
interferon
ifn
may
also
inhibit
spread
unrel
virus
order
investig
antivir
activ
first
analyz
whether
produc
cell
interf
spread
homolog
iav
mdck
cell
fig
mdck
cell
coinfect
indic
dilut
contain
supernat
moi
fig
result
iavdip
ratio
approxim
undilut
dip
contain
supernat
iav
moi
undilut
dip
contain
supernat
iav
moi
undilut
dip
contain
supernat
iav
moi
respect
supernat
wt
cell
transfect
plasmid
product
use
neg
control
control
supernat
appreci
interfer
infect
supernat
cell
effici
block
iav
infect
concentr
depend
manner
highest
antivir
activ
observ
iavdip
ratio
fig
specif
infect
effici
rel
untreat
viru
set
presenc
dip
contain
supernat
dilut
presenc
control
supernat
averag
six
independ
experi
moreov
contain
supernat
also
inhibit
infect
concentr
depend
manner
fig
keep
concept
exert
broad
antiiav
activ
final
contain
supernat
inhibit
vsv
infect
fig
indic
neither
interf
vsv
genom
replic
alter
viral
control
potenti
ifn
respons
mdck
cell
result
show
produc
express
cell
exert
potent
antiiav
activ
product
dip
cocultur
cell
cotransfect
plasmid
harbor
wt
iav
genom
segment
two
eight
subsequ
trypsin
ad
ha
activ
supernat
harvest
indic
time
point
b
quantif
dip
product
cell
inocul
dip
contain
supernat
number
red
cell
count
number
foci
determin
use
focu
format
assay
c
analysi
antivir
activ
dip
mdck
cell
coinfect
iav
wt
dip
follow
focu
format
assay
http
gener
dip
iav
infect
cell
recogn
von
magnu
sever
decad
ago
dip
hold
promis
novel
antivir
agent
howev
exploit
dip
antivir
therapi
requir
effici
product
system
depend
presenc
standard
viru
report
variant
encod
fluoresc
protein
permit
monitor
dip
product
moreov
demonstr
cell
express
microscopi
c
number
infect
cell
determin
red
fluoresc
panel
b
quantifi
parallel
infect
cell
analyz
focu
format
assay
number
foci
quantifi
result
repres
experi
shown
panel
ac
confirm
two
separ
experi
http
two
tail
pair
student
ttest
use
assess
statist
signific
cp
count
per
second
http
new
system
product
defect
interf
particl
allow
gener
infecti
particl
sole
plasmid
absenc
standard
viru
final
studi
show
dip
produc
system
suppress
spread
differ
iav
subtyp
vsv
cell
cultur
particl
dip
far
amplifi
cell
cultur
hen
egg
presenc
standard
viru
addit
product
particl
plasmid
system
describ
approach
reli
transfect
plasmid
product
infecti
iav
conjunct
plasmid
contain
segment
result
coproduct
dip
standard
viru
dip
prepar
produc
system
use
experiment
remain
standard
viru
need
inactiv
uv
light
approach
build
preferenti
inactiv
standard
viru
rel
dip
thu
mutat
gene
essenti
viral
spread
abrog
infect
standard
viru
may
effect
dip
infect
sinc
miss
protein
complement
tran
cell
coinfect
dip
standard
viru
howev
control
effici
uv
inactiv
standard
viru
technic
challeng
moreov
effect
uv
light
dip
infect
difficult
determin
issu
may
complic
larg
scale
product
dip
well
interpret
experiment
data
anim
trial
thu
establish
novel
cell
cultur
system
dip
product
absenc
standard
viru
import
task
result
show
cell
line
express
allow
product
quantif
particl
sole
plasmid
absenc
standard
viru
find
expect
given
sever
report
indic
express
alon
insuffici
allow
robust
spread
iav
variant
temperatur
sensit
mutat
gene
nonpermiss
temperatur
moreov
suggest
express
might
associ
unwant
cytotox
effect
present
studi
suggest
x
particlesml
produc
cell
express
codon
optim
roughli
translat
product
infecti
dip
per
cell
specul
effici
dip
product
increas
employ
cell
line
stabli
coexpress
pa
occasion
weak
fluoresc
observ
dip
inocul
control
cell
like
attribut
low
level
mrna
express
facilit
protein
associ
vrna
present
infect
dip
contrast
evid
product
infecti
iav
due
recombin
rna
rna
encod
obtain
judg
bright
field
microscopi
immunofluoresc
focu
format
assay
rtpcr
analysi
indic
dip
product
system
report
safe
quantif
dip
product
far
reli
quantit
rtpcr
hemagglutin
assay
provid
inform
particl
infect
limit
overcom
present
studi
demonstr
infect
particl
quantifi
use
standard
techniqu
focu
format
assay
avail
new
system
product
defect
interf
particl
method
help
compar
result
obtain
differ
prepar
segment
dip
thu
advanc
develop
dip
antivir
agent
context
noteworthi
iavdip
ratio
result
promin
antivir
activ
hand
similar
ratio
determin
estim
base
quantit
rtpcr
dip
infecti
unit
iav
previous
report
averag
three
moi
moi
six
moi
respect
independ
experi
shown
infect
absenc
supernat
set
error
bar
indic
standard
error
mean
sem
two
tail
pair
student
ttest
use
assess
statist
signific
b
experi
carri
describ
panel
use
infect
averag
three
independ
experi
shown
infect
absenc
supernat
set
error
bar
indic
sem
two
tail
pair
student
ttest
use
assess
statist
signific
c
experi
carri
panel
cell
infect
gfpencod
vsv
supernat
harvest
titrat
h
post
infect
result
singl
repres
experi
conduct
triplic
sampl
shown
confirm
two
separ
experi
http
minim
requir
protect
mice
sever
influenza
thu
studi
confirm
extend
publish
work
indic
dip
provid
vast
excess
exert
antivir
activ
whether
suffici
number
dip
deliv
human
respiratori
tract
remain
stabl
provid
protect
influenza
prolong
time
remain
determin
context
one
specul
iav
dip
ratio
less
might
suffici
antivir
activ
human
sinc
dip
might
exert
direct
antivir
activ
inhibit
iav
genom
replic
induc
ifn
system
moreov
dip
report
long
resid
time
respiratori
tract
mice
diptreat
anim
found
still
protect
one
week
treatment
thu
dip
stabil
respiratori
tract
might
pose
major
hurdl
use
dip
influenza
prevent
therapi
human
final
state
reassort
dip
iav
coinfect
cell
like
occur
howev
dip
base
low
pathogen
relat
virus
use
like
present
studi
reassort
event
result
virus
increas
transmiss
virul
compar
wt
viru
believ
interfer
spread
divers
iav
cell
cultur
due
genom
competit
inde
produc
cell
exert
compar
antivir
activ
iav
statist
signific
differ
keep
polymeras
complex
fulli
function
genom
segment
match
data
publish
gener
use
standard
viru
demonstr
dip
produc
express
cell
fulli
function
although
activ
purifi
dip
remain
examin
also
interfer
spread
influenza
b
viru
ibv
unrel
respiratori
virus
infect
host
thought
due
induct
innat
immun
respons
particularli
ifn
respons
contrast
dipmedi
inhibit
ibv
infect
cell
cultur
observ
due
absenc
genom
competit
absenc
antivir
activ
dip
vsv
confirm
lack
genom
competit
moreov
suggest
dip
might
modul
potenti
ifn
respons
mdck
cell
although
note
respons
might
imped
due
presenc
trypsin
cultur
medium
collect
report
knowledg
first
experiment
system
product
dip
without
standard
viru
quantif
dip
infect
promot
effort
develop
dip
antivir
therapi
winkler
